| Literature DB >> 26966089 |
Jean-François Emile1, Oussama Abla2, Sylvie Fraitag3, Annacarin Horne4, Julien Haroche5, Jean Donadieu6, Luis Requena-Caballero7, Michael B Jordan8, Omar Abdel-Wahab9, Carl E Allen10, Frédéric Charlotte11, Eli L Diamond12, R Maarten Egeler2, Alain Fischer13, Juana Gil Herrera14, Jan-Inge Henter15, Filip Janku16, Miriam Merad17, Jennifer Picarsic18, Carlos Rodriguez-Galindo19, Barret J Rollins20, Abdellatif Tazi21, Robert Vassallo22, Lawrence M Weiss23.
Abstract
The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.Entities:
Mesh:
Year: 2016 PMID: 26966089 PMCID: PMC5161007 DOI: 10.1182/blood-2016-01-690636
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113